CIK 0000879407 · Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460408024
- Phone
- 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,186,600
- in 2 filings
Net −$1,186,600. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-24 | Anzalone Christopher Richard Chief Executive Officer | Option exercise | +9,376 | $2.62 | $25K | 2,141,903 |
| 2019-05-24 | Anzalone Christopher Richard Chief Executive Officer | Option exercise · Stock Option (right to buy) | −40,072 | 1,142,794 | ||
| 2019-05-24 | Anzalone Christopher Richard Chief Executive Officer | Option exercise · Stock Option (right to buy) | −9,376 | 1,133,418 | ||
| 2019-05-21 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −27,071 | $22.00 | $596K | 278,536 |
| 2019-04-03 | Anzalone Christopher Richard Chief Executive Officer | Sale | −50,000 | $19.30 | $965K | 2,092,455 |
| 2019-03-01 | GIVEN BRUCE D Chief Operating Officer | Option exercise | +42,500 | $2.01 | $85K | 687,106 |
| 2019-03-01 | GIVEN BRUCE D Chief Operating Officer | Sale | −42,500 | $19.99 | $850K | 644,606 |
| 2019-03-01 | GIVEN BRUCE D Chief Operating Officer | Option exercise · Stock Option (right to buy) | −42,500 | 350,000 | ||
| 2019-02-26 | GIVEN DOUGLAS B Director | Option exercise | +30,000 | $5.19 | $156K | 205,130 |
| 2019-02-26 | GIVEN DOUGLAS B Director | Option exercise | +18,000 | $2.19 | $39K | 223,130 |
| 2019-02-26 | GIVEN DOUGLAS B Director | Option exercise | +10,000 | $2.62 | $26K | 233,130 |
| 2019-02-26 | GIVEN DOUGLAS B Director | Option exercise | +7,000 | $4.75 | $33K | 240,130 |
| 2019-02-26 | GIVEN DOUGLAS B Director | Sale | −65,000 | $19.25 | $1.3M | 175,130 |
| 2019-02-26 | GIVEN DOUGLAS B Director | Option exercise · Stock Option (right to buy) | −30,000 | 35,000 | ||
| 2019-02-26 | GIVEN DOUGLAS B Director | Option exercise · Stock Option (right to buy) | −18,000 | 17,000 | ||
| 2019-02-26 | GIVEN DOUGLAS B Director | Option exercise · Stock Option (right to buy) | −10,000 | 7,000 | ||
| 2019-02-26 | GIVEN DOUGLAS B Director | Option exercise · Stock Option (right to buy) | −7,000 | 0 | ||
| 2019-02-25 | GIVEN BRUCE D Chief Operating Officer | Option exercise | +42,500 | $2.01 | $85K | 687,106 |
| 2019-02-25 | GIVEN BRUCE D Chief Operating Officer | Sale | −42,500 | $18.98 | $807K | 644,606 |
| 2019-02-25 | GIVEN BRUCE D Chief Operating Officer | Option exercise · Stock Option (right to buy) | −42,500 | 392,500 |
Page 30 of 38 · 752 trades